- Category
- Micro (2021-22)
- Udyam number
- UDYAM-DL-08-0030849

Skyvis Pharma Private Limited
About Skyvis Pharma Private Limited
Data last updated:
Skyvis Pharma Private Limited is a private limited company based in Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 24 February 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2022PTC394292.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Gaurav Prasher and Siddharth Deshpande.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Shop No. Ff – 26 First Floor District Centre Jasola, Delhi, India – 110025.
Skyvis Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0030849).
Company details
Recognitions & Rankings of Skyvis Pharma
Contact details
Skyvis Pharma Private Limited's registered office is in Delhi, Delhi.
- Registered AddressShop No. Ff – 26 First Floor District Centre Jasola, Delhi, India – 110025
- IndustryChemicals, Manufacturing, Basic Chemical
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Skyvis Pharma Private Limited
FY 2024 filings availableFinancial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Skyvis Pharma Private Limited, buy the company report.
Board of directors of Skyvis Pharma Private Limited
Skyvis Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gaurav Prasher | Director | 24 Feb 2022 | 4 Years 8 Months | Current |
| Siddharth Deshpande | Director | 24 Feb 2022 | 4 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving Skyvis Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Skyvis Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Skyvis Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Skyvis Pharma Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Gaurav Prasher was appointed as Director on 24 Feb 2022.
Frequently asked questions
Skyvis Pharma is an active private limited company based in Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 24 February 2022 (4+ years old) and is registered under CIN U24100DL2022PTC394292.
Skyvis Pharma has 2 current directors:
- Gaurav Prasher - Director
- Siddharth Deshpande - Director
The latest financial statements of Skyvis Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Skyvis Pharma is U24100DL2022PTC394292. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Skyvis Pharma was incorporated on 24 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
Gaurav Prasher was appointed as Director on 24 Feb 2022. Siddharth Deshpande was appointed as Director on 24 Feb 2022.
Yes, Skyvis Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-08-0030849).
The registered office of Skyvis Pharma is at Shop No. Ff – 26 First Floor District Centre Jasola, Delhi, India – 110025.
Skyvis Pharma operates in the chemicals industry, in the manufacturing segment.
Skyvis Pharma can be reached at its registered office: Shop No. Ff – 26 First Floor District Centre Jasola, Delhi, India – 110025.

